loadpatents
name:-0.049649000167847
name:-0.043692827224731
name:-0.0024261474609375
Arrowhead Research Corporation Patent Filings

Arrowhead Research Corporation

Patent Applications and Registrations

Patent applications and USPTO patent grants for Arrowhead Research Corporation.The latest application filed is for "low density lipoprotein receptor-mediated sirna delivery".

Company Profile
2.42.22
  • Arrowhead Research Corporation - Pasadena CA US
  • Arrowhead Research Corporation - N/A N/A N/A
  • Arrowhead Research Corporation - Madison WI
  • ARROWHEAD RESEARCH CORPORATION -
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Organic compositions to treat EPAS1-related diseases
Grant 9,868,949 - Bettencourt , et al. January 16, 2
2018-01-16
Interfering RNA delivery system and uses thereof
Grant 9,795,684 - Chatterton October 24, 2
2017-10-24
RNAi-mediated inhibition of histamine receptor H1-related conditions
Grant 9,745,585 - Yanni , et al. August 29, 2
2017-08-29
Transferrin/transferrin receptor-mediated siRNA delivery
Grant 9,562,230 - Chatterton , et al. February 7, 2
2017-02-07
RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
Grant 9,550,994 - Clark , et al. January 24, 2
2017-01-24
Organic compositions to treat HSF1-related diseases
Grant 9,540,643 - Hinkle , et al. January 10, 2
2017-01-10
Low density lipoprotein receptor-mediated siRNA delivery
Grant 9,526,799 - Chatterton December 27, 2
2016-12-27
RNAi inhibition of alpha-ENaC expression
Grant 9,476,052 - Van Heeke , et al. October 25, 2
2016-10-25
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions
Grant 9,476,047 - Chatterton , et al. October 25, 2
2016-10-25
RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders
Grant 9,453,220 - Yanni , et al. September 27, 2
2016-09-27
RNAi-mediated inhibition of tumor necrosis factor .alpha.-related conditions
Grant 9,447,419 - Yanni , et al. September 20, 2
2016-09-20
RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesis
Grant 9,422,556 - Chatterton , et al. August 23, 2
2016-08-23
Organic compositions to treat beta-ENaC-related diseases
Grant 9,376,683 - De Fougerolles , et al. June 28, 2
2016-06-28
RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
Grant 9,371,529 - Yanni , et al. June 21, 2
2016-06-21
LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY
App 20160151514 - Chatterton; Jon E.
2016-06-02
Interfering RNA delivery system and uses thereof
Grant 9,347,062 - Yu , et al. May 24, 2
2016-05-24
Interfering Rna Delivery System And Uses Thereof
App 20160095937 - Chatterton; Jon E.
2016-04-07
Low density lipoprotein receptor-mediated siRNA delivery
Grant 9,289,514 - Chatterton March 22, 2
2016-03-22
RNAi-MEDIATED INHIBITION OF HISTAMINE RECEPTOR H1-RELATED CONDITIONS
App 20160053270 - Yanni; John M. ;   et al.
2016-02-25
Organic Compositions To Treat Epasi-related Diseases
App 20160010089 - Bettencourt; Brian ;   et al.
2016-01-14
Interfering RNA delivery system and uses thereof
Grant 9,233,170 - Chatterton January 12, 2
2016-01-12
RNAi-MEDIATED INHIBITION OF CONNEXIN 43 FOR TREATMENT OF IOP-RELATED CONDITIONS
App 20160002638 - Chatterton; Jon E. ;   et al.
2016-01-07
Modified Small Interfering Rna Molecules And Methods Of Use
App 20150376621 - HAN; Jang ;   et al.
2015-12-31
Modified Small Interfering Rna Molecules And Methods Of Use
App 20150361432 - Han; Jang ;   et al.
2015-12-17
RNAi-mediated inhibition of histamine receptor H1-related conditions
Grant 9,206,428 - Yanni , et al. December 8, 2
2015-12-08
RNAi-Related Inhibition of TNF-alpha Signaling Pathway for Treatment of Ocular Angiogenesis
App 20150344886 - Chatterton; Jon E. ;   et al.
2015-12-03
dsRNA For Treating Viral Infection
App 20150337317 - Labow; Mark Aron ;   et al.
2015-11-26
TRANSFERRIN/TRANSFERRIN RECEPTOR-MEDIATED siRNA DELIVERY
App 20150315592 - Chatterton; Jon E. ;   et al.
2015-11-05
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions
Grant 9,173,896 - Chatterton , et al. November 3, 2
2015-11-03
Rnai-mediatred Inhibition Of Frizzled Related Protein-1 For Treatment Of Glaucoma
App 20150307882 - Clark; Abbot F. ;   et al.
2015-10-29
Organic Compositions To Treat Hsf1-related Diseases
App 20150284721 - HINKLE; Gregory ;   et al.
2015-10-08
RNAi Inhibition of A1pha-ENaC Expression
App 20150284726 - VAN HEEKE; Gino ;   et al.
2015-10-08
siRNA targeting VEGFA and methods for treatment in vivo
Grant 9,150,862 - Smith , et al. October 6, 2
2015-10-06
Organic Compositions to Treat Beta-ENaC-Related diseases
App 20150275218 - DE FOUGEROLLES; Antonin ;   et al.
2015-10-01
RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis
Grant 9,139,834 - Chatterton , et al. September 22, 2
2015-09-22
Modified small interfering RNA molecules and methods of use
Grant 9,139,833 - Han , et al. September 22, 2
2015-09-22
dsRNA for treating viral infection
Grant 9,133,462 - Labow , et al. September 15, 2
2015-09-15
Organic Compositions To Treat Kras-related Diseases
App 20150238515 - Bettencourt; Brian ;   et al.
2015-08-27
Transferrin/transferrin receptor-mediated siRNA delivery
Grant 9,114,152 - Chatterton , et al. August 25, 2
2015-08-25
Organic compositions to treat HSF1-related diseases
Grant 9,096,637 - Hinkle , et al. August 4, 2
2015-08-04
Modified small interfering RNA molecules and methods of use
Grant 9,084,808 - Han , et al. July 21, 2
2015-07-21
Organic compositions to treat Beta-ENaC-related diseases
Grant 9,080,175 - De Fougerolles , et al. July 14, 2
2015-07-14
RNAi inhibition of alpha-ENaC expression
Grant 9,074,212 - Van Heeke , et al. July 7, 2
2015-07-07
Compositions and Methods for Inhibiting Expression of RRM2 Genes
App 20150113670 - Boylan; John Frederick ;   et al.
2015-04-23
Compositions and methods for inhibiting expression of RRM2 genes
Grant 8,946,176 - Boylan , et al. February 3, 2
2015-02-03
Lipid Compounds Targeting VLA-4
App 20130079383 - BENNETT; Michael J. ;   et al.
2013-03-28
Compounds and Compositions for Nucleic Acid Formulation and Delivery
App 20130072543 - Bennett; Michael J. ;   et al.
2013-03-21
Compositions and Methods for Inhibiting Gene Expression of Hepatitis B Virus
App 20130005793 - Chin; Daniel J. ;   et al.
2013-01-03
Novel Lipids and Compositions for Intracellular Delivery of Biologically Active Compounds
App 20120295832 - Constien; Rainer ;   et al.
2012-11-22
GALACTOSE CLUSTER-PHARMACOKINETIC MODULATOR TARGETING MOIETY FOR siRNA
App 20120157509 - Hadwiger; Philipp ;   et al.
2012-06-21
Method for determining an analyte
Grant 7,700,371 - Blank , et al. April 20, 2
2010-04-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed